(Q43509713)

English

Safety and pharmacokinetics of multiple doses of aclidinium bromide, a novel long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease, in healthy participants

scientific article published on 10 July 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Safety and pharmacokinetics of multiple doses of aclidinium bromide, a novel long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease, in healthy participants (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

aclidinium bromide

1 reference

ChEBI release 2020-05-28

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Josep M Jansat

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Rosa Lamarca

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Gonzalo de Miquel

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Andreas Schrödter

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Barbara Miletzki

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Matthias Gurniak

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

publication date

10 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1239-1246

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

1 reference

https://api.crossref.org/works/10.1177%2F0091270009336353

21 January 2018

COPD, a multicomponent disease: implications for management

1 reference

https://api.crossref.org/works/10.1177%2F0091270009336353

21 January 2018

Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1177%2F0091270009336353

21 January 2018

Muscarinic M3 receptors mediate contraction of human central and peripheral airway smooth muscle

1 reference

https://api.crossref.org/works/10.1177%2F0091270009336353

21 January 2018

Cholinergic bronchomotor tone in COPD. Estimates of its amount in comparison with that in normal subjects

1 reference

https://api.crossref.org/works/10.1177%2F0091270009336353

21 January 2018

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1177%2F0091270009336353

21 January 2018

Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F0091270009336353

21 January 2018

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1177%2F0091270009336353

21 January 2018

Novel long-acting bronchodilators for COPD and asthma

1 reference

https://api.crossref.org/works/10.1177%2F0091270009336353

21 January 2018

Combination inhaled bronchodilator therapy in the management of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1177%2F0091270009336353

21 January 2018

The functional impact of adding salmeterol and tiotropium in patients with stable COPD.

1 reference

https://api.crossref.org/works/10.1177%2F0091270009336353

21 January 2018

The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD.

1 reference

https://api.crossref.org/works/10.1177%2F0091270009336353

21 January 2018

Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1177%2F0091270009336353

21 January 2018

Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD.

1 reference

https://api.crossref.org/works/10.1177%2F0091270009336353

21 January 2018

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial

1 reference

https://api.crossref.org/works/10.1177%2F0091270009336353

21 January 2018

Identifiers

10.1177/0091270009336353

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43509713&oldid=2144453774"